)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
China Resources Sanjiu Medical & Pharmaceutical Co (000999) investor relations material
China Resources Sanjiu Medical & Pharmaceutical Co Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary16 Aug, 2025
Executive summary
Operating revenue for 1H2025 grew, reaching RMB 131.87 billion, with gross profit up 2.8% and net profit (excluding non-recurring items) up 1.3%.
Maintained top 3 industry ranking for competitiveness and brand value, with strong positions in manufacturing and distribution.
Completed major acquisitions, including a 28% stake in Tasly, making it a controlling subsidiary and expanding the business portfolio.
Cash flow from operating activities improved significantly, with a 21.03% year-over-year increase to RMB 1.53 billion.
Interim dividend payout ratio was 22%, with a proposed interim dividend of ¥4.5 per 10 shares.
Financial highlights
Revenue reached RMB 131.87 billion (or ¥14.81 billion for the segment), up 2.5–4.99% year-over-year.
Net profit attributable to shareholders (excluding non-recurring items) was RMB 2.47 billion, down 4.7% year-over-year; segment net profit was ¥1.82 billion, down 24.31%.
Operating cash flow improved to RMB 1.53 billion, up 21.03% year-over-year.
Gross margin for pharma segment was 59.74%; self-medication (CHC) segment at 60.50%, prescription drugs at 58.47%.
Total assets increased to RMB 286.85 billion, with segment assets at ¥57.26 billion, up 42.86% from year-end 2024.
Outlook and guidance
Strategic focus on innovation, external development, and operational excellence to achieve high-quality growth under the "15th Five-Year Plan".
Management targets full-year 2025 revenue growth above industry average, aiming for double-digit growth.
Plans to consolidate advantages in TCM, chemical drugs, and distribution, while expanding in biological products, specialty drugs, and high-end medical devices.
Emphasis on digital intelligence, AI, and brand leadership to enhance business efficiency and quality.
Focus on expanding R&D pipeline and leveraging synergies from recent acquisitions.
How does policy support innovation?
M&A integration model details?
Describe digital quality management system.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next China Resources Sanjiu Medical & Pharmaceutical Co earnings date
Q3 202524 Oct, 2025
Next China Resources Sanjiu Medical & Pharmaceutical Co earnings date
Q3 202524 Oct, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is engaged in the research, development, production, and distribution of pharmaceutical products. The company offers a range of prescription and over-the-counter (OTC) medications, as well as traditional Chinese medicine (TCM) products. Its offerings are used to treat various health conditions, including respiratory, digestive, and chronic diseases. The company is headquartered in Shenzhen, China, and its shares are listed on the SZSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage